Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASP1 | P29466 | 5/20 | 0.50 |
| ▸ | CASP3 | P42574 | 3/20 | 0.50 |
| ▸ | CASP9 | P55211 | 3/20 | 0.50 |
| ▸ | CASP7 | P55210 | 1/20 | 0.50 |
| ▸ | GNPAT | O15228 | 1/20 | 0.43 |
| ▸ | TASP1 | Q9H6P5 | 1/20 | 0.43 |
| ▸ | ENPEP | Q07075 | 5/20 | 0.42 |
| ▸ | BACE1 | P56817 | 4/20 | 0.41 |
| ▸ | BACE2 | Q9Y5Z0 | 2/20 | 0.41 |
| ▸ | CASP4 | P49662 | 1/20 | 0.41 |
| ▸ | CASP5 | P51878 | 1/20 | 0.41 |
| ▸ | CASP6 | P55212 | 1/20 | 0.41 |
| ▸ | CASP8 | Q14790 | 1/20 | 0.41 |
| ▸ | CASP10 | Q92851 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | BMP1 | P13497 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13194679 | 1.00 | CASP1 (0.50) | CASP1CASP3CASP9CASP7GNPAT | |
| SCHEMBL29310042 | 1.00 | CASP1 (0.50) | CASP1CASP3CASP9CASP7GNPAT | |
| SCHEMBL4100803 | 1.00 | CASP1 (0.50) | CASP1CASP3CASP9CASP7GNPAT | |
| SCHEMBL10068454 | 0.98 | CASP1 (0.47) | CASP1CASP3CASP9CASP7GNPAT | |
| SCHEMBL29802264 | 0.93 | TASP1 (0.51) | CASP1CASP3CASP9CASP7TASP1 | |
| SCHEMBL20257260 | 0.91 | TASP1 (0.53) | CASP1CASP3CASP9CASP7TASP1 | |
| SCHEMBL20257263 | 0.91 | TASP1 (0.53) | CASP1CASP3CASP9CASP7TASP1 | |
| SCHEMBL29664642 | 0.87 | CASP1 (0.47) | CASP1CASP3CASP9CASP7ENPEP | |
| SCHEMBL23133189 | 0.87 | CASP1 (0.49) | CASP1CASP3CASP9CASP7GNPAT | |
| SCHEMBL23133187 | 0.87 | CASP1 (0.49) | CASP1CASP3CASP9CASP7GNPAT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 144 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119000835-A | Preparation method of cylindrical magnetic bio-MOF modified electrode and application of cylindrical magnetic bio-MOF modified electrode in Caspase-3 detection | 宁波大学 | 2024-11-22 | — | — | CN | claimed |
| US-20240287457-A1 | COMPOSITIONS AND CELL CULTURE MEDIA FOR INCREASING NEUTROPHIL LIFESPAN | THE CHILDREN'S MEDICAL CENTER CORPORATION (US) | 2024-08-29 | — | — | US | claimed |
| US-20240268372-A1 | Methods and Compositions for Extending Organ and Tissue Preservation | MASSACHUSETTS GEN HOSPITAL (US) | 2024-08-15 | — | — | US | claimed |
| CN-118044505-A | Fresh tissue preservation solution and preparation method and application thereof | 北京百奥智汇科技有限公司 | 2024-05-17 | — | — | CN | claimed |
| CN-118048314-A | Preparation method of additive factors for enhancing hybridoma fusion | 苏州博特龙免疫技术有限公司 | 2024-05-17 | — | — | CN | claimed |
| US-20240115649-A1 | CASPASE INHIBITION TO ENHANCE REGENERATION AND REPAIR AFTER SKIN OR GUT INJURY AND TO TREAT BACTERIAL OR VIRAL INFECTIONS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2024-04-11 | — | — | US | claimed |
| US-11879893-B2 | Rapid detection test for SARS-CoV-2 | NLC PHARMA LTD (IL) | 2024-01-23 | — | — | US | claimed |
| CN-117004565-A | Culture combination and culture method for obtaining T cells from cryopreserved PBMC | 上海细胞治疗集团有限公司 | 2023-11-07 | — | — | CN | claimed |
| CN-114891726-B | Human totipotent stem cell induction culture medium and application thereof | 中山大学 | 2023-04-28 | — | — | CN | claimed |
| US-20230090502-A1 | RAPID DETECTION TEST FOR SARS-COV-2 | NLC PHARMA LTD (IL) | 2023-03-23 | — | — | US | claimed |
| WO-2022266046-A1 | COMPOSITIONS AND CELL CULTURE MEDIA FOR INCREASING NEUTROPHIL LIFESPAN | THE CHILDREN'S MEDICAL CENTER CORPORATION (US) | 2022-12-22 | — | — | WO | claimed |
| EP-4097244-A2 | RAPID DETECTION TEST FOR SARS-COV-2 | NLC Pharma Ltd (IL) | 2022-12-07 | — | — | EP | claimed |
| CN-115386538-A | Method for separating, extracting and culturing endometrial stem cells from menstrual blood and special culture medium | 上海长一干细胞研究中心有限公司 | 2022-11-25 | — | — | CN | claimed |
| CN-115381445-A | Menstrual blood collector for human menstrual blood, preservation solution and matched preservation and transportation device | 上海长一干细胞研究中心有限公司 | 2022-11-25 | — | — | CN | claimed |
| WO-2022241417-A1 | METHODS AND COMPOSITIONS FOR EXTENDING ORGAN AND TISSUE PRESERVATION | THE GENERAL HOSPITAL CORPORATION (US) | 2022-11-17 | — | — | WO | claimed |
| CN-115335532-A | SARS-COV-2 quick detection test | NLC制药有限公司 | 2022-11-11 | — | — | CN | claimed |
| CN-114891726-A | Human totipotent-like stem cell induction culture medium and application thereof | 中山大学 | 2022-08-12 | — | — | CN | claimed |
| US-20260137691-A1 | WB3 FOR ANESTHESIA AND TREATING PAIN | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2026-05-21 | — | — | US | disclosed |
| WO-1999041398-A1 | VECTORS, CELLS AND METHODS FOR THE PRODUCTION OF DELETERIOUS VIRAL EUKARYOTIC GENE TRANSFER VECTORS | GENVEC, INC. (US) | 1999-08-19 | — | — | WO | disclosed |
| WO-1999009208-A1 | METHOD AND REAGENT FOR MONITORING APOPTOSIS AND DISTINGUISHING APOPTOSIS FROM NECROSIS | COULTER INTERNATIONAL CORP. (US) | 1999-02-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260137691-A1 | WB3 FOR ANESTHESIA AND TREATING PAIN | WNT3, TRPV3, ADRB3 | CASP1 628/4885CASP3 39/4885CASP9 845/4885 |
| US-20240287457-A1 | COMPOSITIONS AND CELL CULTURE MEDIA FOR INCREASING NEUTROPHIL LIFESPAN | MMP8, NCF1, ELANE | CASP1 106/4885CASP3 595/4885CASP9 294/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.